Application Sponsors
ANDA 208860 | MYLAN LABS LTD | |
Marketing Status
Application Products
001 | SOLUTION;INTRAVENOUS | 20MG/20ML (1MG/ML) | 0 | CLOFARABINE | CLOFARABINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2017-11-06 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2021-05-19 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2023-01-09 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 2 | Null | 15 |
SUPPL | 7 | Null | 7 |
TE Codes
CDER Filings
MYLAN LABS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 208860
[companyName] => MYLAN LABS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"CLOFARABINE","activeIngredients":"CLOFARABINE","strength":"20MG\/20ML (1MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"11\/06\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2017-11-06
)
)